De-Escalated Therapy for HR+/HER2+ Breast Cancer Patients With Ki67 Response After 2 Weeks Letrozole: Results of the PerELISA Neoadjuvant Study

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdz055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Erratum To: Tumor-Infiltrating Lymphocytes and Molecular Response After Neoadjuvant Therapy for HR+/HER2− Breast Cancer: Results From Two Prospective Trials

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2015English

Ribociclib With Letrozole vs Letrozole Alone in Elderly Patients With Hormone Receptor-Positive, HER2-negative Breast Cancer in the Randomized MONALEESA-2 Trial

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Response to Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study

International Journal of Breast Cancer
Cancer ResearchOncologyPharmacology
2015English

18f-Fluorodeoxyglucose (FDG) PET/CT After Two Cycles of Neoadjuvant Therapy May Predict Response in HER2-negative, but Not in HER2-positive Breast Cancer

Oncotarget
Oncology
2015English

Pathologic Evaluation of Breast Cancer After Neoadjuvant Therapy

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy